+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
MET TKIs Market - Global Forecast 2025-2030- Product Image
MET TKIs Market - Global Forecast 2025-2030- Product Image
Sale

MET TKIs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129656
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The MET tyrosine kinase inhibitors (MET TKIs) market is advancing rapidly as targeted therapies revolutionize oncology care by aligning treatments to specific molecular alterations. Stakeholders across the pharmaceutical value chain are navigating an evolving landscape shaped by scientific breakthroughs, regulatory trends, and new commercialization models.

Market Snapshot: MET Tyrosine Kinase Inhibitors Market

The MET TKI global market is driven by demand for innovative therapeutics addressing MET alterations in cancer patients. This growth reflects strong investment in research, continuous regulatory approvals, and expanding adoption across hospital, clinic, and outpatient settings. Advancements in biomarker technologies and treatment personalization further support robust growth, positioning the market for sustained expansion. The sector’s trajectory is reinforced by shifting clinical adoption strategies, wider patient access initiatives, and new alliances among major industry players.

Scope & Segmentation

This report delivers a comprehensive analysis of the MET TKI market, highlighting its pivotal segmentation variables and geographic diversity:

  • Route Of Administration: Oral and intravenous formats serve varied patient needs in clinical and acute settings.
  • Dosage Form: Includes capsule, injection, and tablet, balancing patient preferences with cost and therapeutic requirements.
  • End User: Targets clinics, hospitals, and specialty centers, each with unique adoption patterns and infrastructure.
  • Indication: Focuses on hepatocellular carcinoma, non-small cell lung cancer, and papillary renal cell carcinoma to address diverse oncology pathways.
  • Distribution Channel: Features hospital pharmacies, online pharmacies, and retail pharmacies, optimizing product flow from manufacturer to patient.
  • Molecular Alteration: Considers agents targeting exon14 skipping mutation, MET amplification, and MET fusion across development and treatment strategies.
  • Regions Covered: Americas (with analysis including the United States, major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (encompassing UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, and selected Southeast Asian countries).
  • Leading Companies: Active participants include Novartis AG, Merck KGaA, Pfizer Inc., Exelixis, Inc., and Hutchison China MediTech Limited.

Key Takeaways & Strategic Insights

  • Targeted MET TKIs enable precision therapy for cancer cases previously resistant to conventional regimens, supporting personalized medicine strategies.
  • The market is impacted by ongoing adaptation to regulatory frameworks, with shifting trial designs accelerating drug review and approval cycles.
  • Integration of advanced biomarkers in clinical trials enhances patient stratification, amplifying the clinical and commercial potential of selective MET inhibitors.
  • Collaboration among pharmaceutical developers, diagnostics providers, and health systems is crucial for market access and competitive differentiation.
  • Technological advances such as digital health platforms and real-world evidence analytics are fostering more responsive patient care models and improving long-term therapy monitoring.
  • Pipeline and partnership activity, including in-licensing and joint development agreements, is intensifying as firms race to address unmet needs and expand their portfolios.

Tariff Impact: United States 2025 Implications

The 2025 introduction of new US tariffs on key active pharmaceutical ingredients and finished MET TKI products has increased manufacturing costs and redefined supply chain strategies. Industry leaders are responding by diversifying production, forming local partnerships, and investing in process optimizations to minimize risks associated with duties. Procurement and pricing strategies have shifted toward value-based agreements and adaptive commercialization models, which have proven essential in maintaining patient access and managing costs amid these new trade dynamics.

Methodology & Data Sources

The findings are based on a multi-stage research process, combining secondary literature review, detailed expert interviews (with oncologists, regulatory specialists, and reimbursement professionals), and extensive data triangulation from clinical registries, approval databases, and company disclosures. Scope and accuracy have been ensured through internal peer review and validation of real-world usage patterns.

Why This Report Matters

  • Enables senior decision-makers to develop market entry, R&D, and commercialization strategies guided by actionable segmentation and regional intelligence.
  • Supports investment decisions and risk management by providing a clear understanding of the scientific, regulatory, and competitive drivers in MET TKIs.
  • Equips organizations to anticipate clinical adoption trends, respond to tariff disruptions, and maximize stakeholder engagement in oncology.

Conclusion

The MET TKI market is distinguished by innovation, competition, and regulatory evolution driving improved patient outcomes. Organizations that leverage these insights and adapt to shifting dynamics will be best positioned for success in a complex oncology environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of MET exon 14 skipping companion diagnostics to guide targeted therapy selection
5.2. Emergence of next generation MET TKIs designed to overcome secondary resistance mutations in NSCLC patients
5.3. Growing investment in combination regimens pairing MET TKIs with immune checkpoint inhibitors for synergistic efficacy
5.4. Expansion of MET TKI clinical trials into non-small cell lung cancer and rare solid tumors with MET amplification
5.5. Rising competition from novel MET and multikinase inhibitors driving strategic partnerships and licensing agreements
5.6. Increasing availability of real world evidence influencing pricing, reimbursement and market access decisions for MET TKIs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. MET TKIs Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
9. MET TKIs Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Injection
9.4. Tablet
10. MET TKIs Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
10.4. Specialty Centers
11. MET TKIs Market, by Indication
11.1. Introduction
11.2. Hepatocellular Carcinoma
11.3. Non-Small Cell Lung Cancer
11.4. Papillary Renal Cell Carcinoma
12. MET TKIs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. MET TKIs Market, by Molecular Alteration
13.1. Introduction
13.2. Exon14 Skipping Mutation
13.3. MET Amplification
13.4. MET Fusion
14. Americas MET TKIs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa MET TKIs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific MET TKIs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novartis AG
17.3.2. Merck KGaA
17.3.3. Pfizer Inc.
17.3.4. Exelixis, Inc.
17.3.5. Hutchison China MediTech Limited
18. ResearchAI19. ResearchStatistics20. ResearchContacts21. ResearchArticles22. Appendix
List of Figures
FIGURE 1. MET TKIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MET TKIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MET TKIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MET TKIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MET TKIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MET TKIS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MET TKIS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MET TKIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MET TKIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MET TKIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MET TKIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MET TKIS MARKET: RESEARCHAI
FIGURE 28. MET TKIS MARKET: RESEARCHSTATISTICS
FIGURE 29. MET TKIS MARKET: RESEARCHCONTACTS
FIGURE 30. MET TKIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MET TKIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MET TKIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MET TKIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MET TKIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MET TKIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MET TKIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MET TKIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MET TKIS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MET TKIS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MET TKIS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MET TKIS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MET TKIS MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MET TKIS MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MET TKIS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MET TKIS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MET TKIS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MET TKIS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MET TKIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MET TKIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MET TKIS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MET TKIS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MET TKIS MARKET SIZE, BY HEPATOCELLULAR CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MET TKIS MARKET SIZE, BY HEPATOCELLULAR CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MET TKIS MARKET SIZE, BY NON-SMALL CELL LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MET TKIS MARKET SIZE, BY NON-SMALL CELL LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MET TKIS MARKET SIZE, BY PAPILLARY RENAL CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MET TKIS MARKET SIZE, BY PAPILLARY RENAL CELL CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MET TKIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MET TKIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MET TKIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MET TKIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MET TKIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MET TKIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MET TKIS MARKET SIZE, BY EXON14 SKIPPING MUTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MET TKIS MARKET SIZE, BY EXON14 SKIPPING MUTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MET TKIS MARKET SIZE, BY MET AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MET TKIS MARKET SIZE, BY MET AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MET TKIS MARKET SIZE, BY MET FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MET TKIS MARKET SIZE, BY MET FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES MET TKIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES MET TKIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 83. CANADA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 84. CANADA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 85. CANADA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 86. CANADA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 87. CANADA MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. CANADA MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. CANADA MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. CANADA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. CANADA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. CANADA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. MEXICO MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. MEXICO MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 98. MEXICO MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 99. MEXICO MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. MEXICO MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. MEXICO MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. MEXICO MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 157. GERMANY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. GERMANY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. GERMANY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 160. GERMANY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 161. GERMANY MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. GERMANY MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. GERMANY MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. GERMANY MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. GERMANY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. GERMANY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. GERMANY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 169. FRANCE MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. FRANCE MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. FRANCE MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. FRANCE MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. FRANCE MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. FRANCE MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. FRANCE MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. FRANCE MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. FRANCE MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. FRANCE MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. FRANCE MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 193. ITALY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ITALY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ITALY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 196. ITALY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 197. ITALY MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ITALY MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ITALY MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. ITALY MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. ITALY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. ITALY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. ITALY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 205. SPAIN MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. SPAIN MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. SPAIN MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 208. SPAIN MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 209. SPAIN MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. SPAIN MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. SPAIN MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. SPAIN MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. SPAIN MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. SPAIN MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. SPAIN MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 253. DENMARK MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. DENMARK MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. DENMARK MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. DENMARK MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. DENMARK MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. DENMARK MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. DENMARK MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. DENMARK MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. DENMARK MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. DENMARK MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. DENMARK MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 277. QATAR MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. QATAR MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. QATAR MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. QATAR MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. QATAR MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. QATAR MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. QATAR MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. QATAR MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. QATAR MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. QATAR MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. QATAR MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 289. FINLAND MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. FINLAND MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. FINLAND MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. FINLAND MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. FINLAND MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FINLAND MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FINLAND MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. FINLAND MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. FINLAND MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. FINLAND MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. FINLAND MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 325. EGYPT MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 326. EGYPT MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 327. EGYPT MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 328. EGYPT MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 329. EGYPT MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. EGYPT MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. EGYPT MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 332. EGYPT MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 333. EGYPT MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. EGYPT MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. EGYPT MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 336. EGYPT MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 337. TURKEY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 338. TURKEY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 339. TURKEY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 340. TURKEY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 341. TURKEY MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. TURKEY MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. TURKEY MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 344. TURKEY MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 345. TURKEY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. TURKEY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. TURKEY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 348. TURKEY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 351. ISRAEL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 352. ISRAEL MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 353. ISRAEL MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 354. ISRAEL MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 355. ISRAEL MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 356. ISRAEL MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 357. ISRAEL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 358. ISRAEL MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 359. ISRAEL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 360. ISRAEL MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 361. NORWAY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 362. NORWAY MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 363. NORWAY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 364. NORWAY MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 365. NORWAY MET TKIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 366. NORWAY MET TKIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 367. NORWAY MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 368. NORWAY MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 369. NORWAY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 370. NORWAY MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 371. NORWAY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2018-2024 (USD MILLION)
TABLE 372. NORWAY MET TKIS MARKET SIZE, BY MOLECULAR ALTERATION, 2025-2030 (USD MILLION)
TABLE 373. POLAND MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 374. POLAND MET TKIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 375. POLAND MET TKIS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 376. POLAND MET TKIS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 377. POLAND MET TKIS MARKET SIZE, BY END US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this MET TKIs Market report include:
  • Novartis AG
  • Merck KGaA
  • Pfizer Inc.
  • Exelixis, Inc.
  • Hutchison China MediTech Limited

Related Reports

Single-target MET TKIs Market - Global Forecast 2025-2030 - Product Image

Single-target MET TKIs Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Multi-target MET TKIs Market - Global Forecast 2025-2030 - Product Image

Multi-target MET TKIs Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025 - Product Image

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Non-Small Cell Lung Cancer - Market Insight, Epidemiology, and Market Forecast -2034 - Product Image

Non-Small Cell Lung Cancer - Market Insight, Epidemiology, and Market Forecast -2034

  • Report
  • 880 Pages
  • Global
From
Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC) - Product Image

Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)

  • Report
  • 15 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.